Biomarkers of oxidative stress and the relationship to cigarette smoking

Mini-Reviews in Organic Chemistry

Volumn 8, Issue 4, 2011, Pages 377-386

  Lowe, F J ^a   Cemeli, E ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

Author keywords

8 hydroxydeoxyguanosine; Antioxidant; Biomarker; Isoprostane; LDL cholesterol; Malondialdehyde; Oxidative stress; Smoking

Indexed keywords

EID: 80053485433     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019311797440308     Document Type: Review

References (166)

1. Rodgman, A.; Perfetti, T. The Chemical Components of Tobacco and Tobacco Smoke; CRC Press: Winston-Salem, 2009.
2. Yanbaeva, D.G.; Dentener, M.A.; Creutzberg, E.C.; Wesseling, G.; Wouters, E.M.F. Systemic effects of smoking. Chest, 2007, 131(5), 1557-1566.
3. Dalle-Donne, I.; Rossi, R.; Colombo, R.; Giustarini, D.; Milzani, A. Biomarkers of oxidative damage in human disease. Clin. Chem., 2006, 52(4), 601-623.
4. van der Vaart, H., Postma, D.S.; Timens, W.; ten Hacken, N.H. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax, 2004, 59(8), 713-721.
5. Liebler, D.C.; Reed, D.J. In: Free Radical Toxicology; Wallance, Ed.; Publisher Press: New York, 1999, pp. 490-495.
6. Ceylan, E.; Kocyigit, A.; Gencer, M.; Aksoy, N.; Selek, S. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir. Med., 2006, 100(7), 1270-1276.
7. Tanriverdi, H.; Evrengul, H.; Kuru, O.; Tanriverdi, S.; Seleci, D.; Enli, Y.; Kaftan, H.A.; Kilic, M. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ. J., 2006, 70(5), 593-599.
8. Fahn, H.J.; Wang, L.S.; Kao, S.H.; Chang, S.C.; Huang, M.H.; Wei, Y.H. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am. J. Respir. Cell Mol. Biol., 1998, 19(6), 901-909.
9. Lykkesfeldt, J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin. Chim. Acta, 2007, 380(1-2), 50-58.
10. Kim, S.H.; Kim, J.S.; Shin, H.S.; Keen, C.L. Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition, 2003, 19, 240-243.
11. Durak, I.; Elgun, S.; Bingol, N.K. Effects of cigarette smoking with different tar content on erythrocyte oxidant/antioxidant status. Addict. Biol., 2002, 7, 255-258.
12. Isik, B.; Ceylan, A.; Isik, R. Oxidative stress in smokers and non-smokers. Inhal. Toxicol., 2007, 19(9), 767-769.
13. Zhang, X.Y.; Tan, Y.L.; Zhou, D.F.; Haile, C.N.; Wu, G.Y.; Cao, L.Y.; Kosten, T.A.; Kosten, T.R. Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology, 2007, 32(9), 2020-2024.
14. Ermis, B.; Ors, R.; Yildirim, A.; Tastekin, A.; Kardas, F.; Akcay, F. Influence of smoking on maternal and neonatal serum malondialdehyde, superoxide dismutase, and glutathione peroxidase levels. Ann. Clin. Lab. Sci., 2004, 34(4), 405-409.
15. Ermis, B.; Yildirim, A.; Ors, R.; Tastekin, A.; Ozkan, B.; Akcay, F. Influence of smoking on serum and milk malondialdehyde, superoxide dismutase, glutathione peroxidase, and antioxidant potential levels in mothers at the postpartum seventh day. Biol. Trace Elem. Res., 2005, 105(1-3), 27-36.
16. Chávez, J.; Cano, C.; Souki, A.; Bermúdez, V.; Medina, M.; Ciszek, A.; Amell, A.; Vargas, M.E.; Reyna, N.; Toledo, A.; Cano, R.; Suárez, G.; Contreras, F.; Israili, Z.H.; Hernández-Hernández, R.; Valasco M. Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjects. Am. J. Ther., 2007, 14(2), 189-193.
17. Ozguner, F.; Koyu, A.; Cesur, G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol. Ind. Health, 2005, 21(1-2), 21-26.
18. Alberg, A.J. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology, 2002, 180, 121-137.
19. Bloomer, R.J. Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: Impact of dietary intake. Nutr. J., 2007 6, 39.
20. Rang, H.P.; Dale, M.M.; Ritter J.M. Pharmacology, 4th ed.; Churchill Livingstone: Edinburgh, 1999.
21. Morrow, J.D.; Hill, K.E.; Burk, R.F.; Nammour, T.M.; Badr, K.F.; Roberts II, L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA, 1990, 87, 9383-9387.
22. Morrow, J.D.; Harris, T.M.; Roberts, II L.J. Noncycoloxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal. Biochem., 1990, 184, 1-10.
23. ∞, a potent agonist of the vascular thromboxane/ endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins, 1992, 44, 155-163.
24. Janssen, L.J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am. J. Physiol. Lung Cell. Mol. Physiol., 2001, 280, L1067-L1082.
25. Church, D.F.; Pryor, W.A. Free radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect., 1985, 64, 111-126.
26. Faux, S.P.; Tai, T.; Thorne, D.; Xu, Y.; Breheny, D.; Gacam, M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers, 2009, 14(1), 90-96.
27. Morrow, J.D.; Frei, B.; Longmire, A.W.; Gaziano, J.M.; Lynch, S.M.; Shyr, Y.; Strauss, W.E.; Oates, J.A.; Roberts, II L.J. Increase in circulating products of lipid peroxidation (F2 Isoprostanes) in smokers. N. Engl. J. Med., 1995, 332(18), 1198-1203.
28. Keaney, J.F.; Larson, M.G.; Vasan, R.S.; Wilson, P.F.; Lipinska, I.; Corey, D.; Massaro, J.M.; Sutherland, P.; Vita, J.A.; Benjamin, E.J. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 434-439.
29. Liang, Y.; Wei, P.; Duke, R.W.; Reaven, P.D.; Harman, S.M.; Cutler, R.G.; Heward, C.B. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor- 8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatographytandem mass spectrometry. Free Radic. Biol. Med., 2003, 34(4), 409-418.
30. Oguogho, A.; Lupattelli, G.; Palumbo, B.; Sinzinger, H. Isoprostanes quickly normalise after quitting cigarette smoking in healthy adults. VASA, 2000, 29, 103-105.
31. Harman, S.M.; Liang, L.; Tsitouras, P.D.; Gucciardo, F.; Heward, C.B.; Reaven, P.D.; Ping, W.; Ahmed, A.; Cutler, R.G. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic. Biol. Med., 2003, 35(10), 1301-9.
32. Lowe, F.J.; Gregg, E.O.; McEwan, M. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clin. Chem. Lab. Med., 2009, 47(3), 311-320.
33. Zedler, B.K.; Kinser, R.; Oey, J.; Nelson, B.; Roethig, H.J.; Walk, R.A.; Kuhl, P.; Rustemeier, K.; Schepers, G.; Von Holt, K.; Tricker, A.R. Biomarkers of exposure and potential harm in adult smokers of 3-7mg tar yield cigarettes and in adult non-smokers. Biomarkers, 2006, 11(3), 201-220.
34. Montuschi, P.; Collins, J.V.; Ciabattoni, G.; Lazzeri, N.; Corradi, M.; Kharitonov, S.A.; Barnes, P.J. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med., 2000, 162(3 Pt 1), 1175-1177.
35. Borrill, Z.L.; Roy, K.; Vessey, R.S.; Woodcock, A.A.; Singh, D. Noninvasive biomarkers and pulmonary function in smokers. Int. J. Chron. Obstruct. Pulmon Dis., 2008, 3(1), 171-183.
36. Reilly, M.P.; Delanty, N.; Lawson, J.A.; Fitzgerald,G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation, 1996, 94(1), 19-25.
37. Gopaul, N.K.; Nourooz-Zadeh, J.; Mallet, A.I.; Anggard, E.E. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem. Biophys. Res. Commun., 1994, 200, 338-343.
38. Papaioannou, A.I.; Koutsokera, A.; Tanou, K.; Kiropoulos, T.S.; Tsilioni, I.; Oikonomidi, S.; Liadaki, K.; Pournaras, S.; Gourgoulianis, K.I.; Kostikas, K. The acute effect of smoking in healthy and asthmatic smokers. Eur. J. Clin. Invest., 2010, 40(2),103-109
39. Mazur, W.; Stark, H.; Sovijärvi, A.; Myllärniemi, M.; Kinnula, V.L. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers. Respiration, 2009, 78(2), 209-216.
40. Dalaveris, E.; Kerenidi, T.; Katsabeki-Katsafli, A.; Kiropoulos, T.; Tanou, K.; Gourgoulianis, K.I.; Kostikas, K. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer, 2009, 64(2), 219-225.
41. Holvoet, P. Oxidized LDL and coronary heart disease. Acta Cardiol., 2004, 59, 479-484.
42. Hulthe, J. Antibodies to oxidized LDL in atherosclerosis development- clinical and animal studies. Clin. Chim. Acta, 2004, 348, 1-8.
43. Vicca, S.; Massy, Z.A.; Hennequin, C.; Rihane, D.; Nguyen-Khoa, T.; Drueke, T.B.; Lacour, B. New insights into the effects of the protein moiety of oxidized LDL (oxLDL). Kidney Int. Suppl., 2003, S125-S127.
44. Frostegard, J. Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun. Rev., 2002, 1, 233-237.
45. Boullier, A.; Bird, D.A.; Chang, M.K.; Dennis, E.A.; Friedman, P.; Gillotre- Taylor, K.; Horkko, S.; Palinski, W.; Quehenberger, O.; Shaw, P.; Steinberg, D.; Terpstra, V.; Witztum, J.L. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann. N Y Acad. Sci., 2001, 947, 214-222.
46. Kita, T.; Kume, N.; Minami, M.; Hayashida, K.; Murayama, T.; Sano, H.; Moriwaki, H.; Kataoka, H.; Nishi, E.; Horiuchi, H.; Arai, H.; Yokode, M. Role of oxidized LDL in atherosclerosis. Ann. N Y Acad. Sci., 2001, 947, 199-205.
47. Kita, T.; Kume, N.; Yokode, M.; Ishii, K.; Arai, H.; Horiuchi, H.; Moriwaki, H.; Minami, M.; Kataoka, H.; Wakatsuki, Y. Oxidized-LDL and atherosclerosis. Role of LOX-1. Ann. N Y Acad. Sci., 2000, 902, 95-100.
48. Holvoet, P.; Vanhaecke, J.; Janssens, S.; Van de, W.F.; Collen, D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation, 1998, 98, 1487-1494.
49. Yamaguchi, Y.; Matsuno, S.; Kagota, S.; Haginaka, J.; Kunitomo, M. Peroxynitrite- mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis, 2004, 172, 259-265.
50. Hsiai, T.K.; Hwang, J.; Barr, M.L.; Correa, A.; Hamilton, R.; Alavi, M.; Rouhanizadeh, M.; Cadenas, E.; Hazen, S.L. Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B- 100 nitration. Free Radic. Biol. Med., 2007, 42, 519-529.
51. Brouwers, A.; Langlois, M.; Delanghe, J.; Billiet, J.; De Buyzere, M.; Vercaemst, R.; Rietzschel, E.; Bernard, D.; Blaton, V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis, 2004, 176, 189-195.
52. Kassi, E.; Dalamaga, M.; Faviou, E.; Hroussalas, G.; Kazanis, K.; Nounopoulos, C.; Dionyssiou-Asteriou, A. Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women. Atherosclerosis, 2009, 205(1), 279-283
53. Chen, H.W.; Kuo, C.L.; Huang, C.S.; Kuo, S.J.; Liu, C.S. Oxidized lowdensity lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population. Cardiology, 2007, 110, 252-259.
54. Duntas, L.H.; Mantzou, E.; Koutras, D.A. Circulating levels of oxidized low density lipoprotein in overt and mild hypothyroidism. Thyroid, 2002, 12, 1003-1007.
55. Mosca, L.; Rubenfire, M.; Tarshis, T.; Tsai, A.; Pearson, T. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. Am. J. Cardiol., 1997, 80, 825-830.
56. Panagiotakos, D.B.; Pitsavos, C.; Chrysohoou, C.; Skoumas, J.; Masoura, C.; Toutouzas, P.; Stefanadis, C. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am. J. Med., 2004, 116, 145-150.
57. Yoshida, H.; Sasaki, K.; Hirowatari, Y.; Kurosawa, H.; Sato, N.; Furutani, N.; Tada, N. Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase. Clin. Chim. Acta, 2004, 345, 161-170.
58. Holvoet, P.; Harris, T.B.; Tracy, R.P.; Verhamme, P.; Newman, A.B.; Rubin, S.M.; Simonsick, E.M.; Colbert, L.H.; Kritchevsky, S.B. Association of high coronary heart disease risk status with circulating oxidized LDL in the wellfunctioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 1444-1448.
59. Matsumoto, T.; Takashima, H.; Ohira, N.; Tarutani, Y.; Yasuda, Y.; Yamane, T.; Matsuo, S.; Horie, M. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin. J. Am. Coll. Cardiol., 2004, 44, 451-457.
60. Meisinger, C.; Baumert, J.; Khuseyinova, N.; Loewel, H.; Koenig, W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation, 2005, 112, 651-657.
61. Jialal, I.; Devaraj, S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin. Chem., 1996, 42, 498-506.
62. Ahotupa, M.; Asankari, T.J. Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. Free Radic. Biol. Med., 1999, 27, 1141-1150.
63. Brown, K.M.; Morrice, P.C.; Duthie, G.G. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am. J. Clin. Nutr., 1994, 60, 383-387.
64. Tsimikas, S.; Witztum, J.L. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation, 2001, 103, 1930-1932.
65. Shoji, T.; Nishizawa, Y.; Fukumoto, M.; Shimamura, K.; Kimura, J.; Kanda, H.; Emoto, M.; Kawagishi, T.; Morii, H. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis, 2000, 148, 171-177.
66. Shoji, T.; Kimoto, E.; Shinohara, K.; Emoto, M.; Ishimura, E.; Miki, T.; Tsujimoto, Y.; Tabata, T.; Nishizawa, Y. The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients. Kidney Int. Suppl., 2003, S128-S130.
67. Fagerberg, B.; Bokemark, L.; Hulthe, J. The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men. Nutr. Metab. Cardiovasc. Dis., 2001, 11, 227-235.
68. Heitzer, T.; Yla-Herttuala, S.; Luoma, J.; Kurz, S.; Munzel, T.; Just, H.; Olschewski, M.; Drexler, H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation, 1996, 93, 1346-1353.
69. Heitzer, T.; Yla, H.S.; Wild, E.; Luoma, J.; Drexler, H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both. J. Am. Coll. Cardiol., 1999, 33, 499-505.
70. Kwon, K.H.; Kwon, H.M.; Hong, B.K.; Kim, D.S.; Lee, J.Y.; Ryu, S.K.; Park, B.E.; Park, H.Y.; Kim, J.H.; Yoon, Y.W.; Cho, S.Y.; Kim, H.S. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with nondiabetic unstable angina: a potential role in immunologic reaction of plaque instability. Yonsei Med. J., 2002, 43, 203-210.
71. Lehtimaki, T.; Lehtinen, S.; Solakivi, T.; Nikkila, M.; Jaakkola, O.; Jokela, H.; Yla-Herttuala, S.; Luoma, J.S.; Koivula, T.; Nikkari, T. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 23-27.
72. Liu, C.S.; Lii, C.K.; Ou, C.C.; Tsai, C.H.; Wei, Y.H.; Chen, H.W. Autoantibody against oxidized low-density lipoproteins may be enhanced by cigarette smoking. Chem. Biol. Interact., 2000, 127, 125-137.
73. Van Tits, L.J.; de Waart, F.; Hak-Lemmers, H.L.; van Heijst, P.; de Graaf, J.; Demacker, P.N.; Stalenhoef, A.F. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radic. Biol. Med., 2001, 30, 1122-1129.
74. Boullier, A.; Hamon, M.; Walters-Laporte, E.; Martin-Nizart, F.; Mackereel, R.; Fruchart, J.C.; Bertrand, M.; Duriez, P. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin. Chim. Acta, 1995, 238, 1-10.
75. Di Bari, M.; Zacchei, S.; Kritchevsky, S.B.; Anichini, M.; Cesaretti, S.; Chiarlone, M.; Masotti, G.; Marchionni, N. Anti-oxidized LDL antibodies and wine consumption: a population-based epidemiological study in Dicomano, Italy. Ann. Epidemiol., 2003, 13, 189-195.
76. Hoogerbrugge, N.; Zillikens, M.C.; Jansen, H.; Meeter, K.; Deckers, J.W.; Birkenhager, J.C. Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease. Metabolism, 1998, 47, 675-680.
77. Marangon, K.; Herbeth, B.; Artur, Y.; Esterbauer, H.; Siest, G. Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers. Clin. Chim. Acta, 1997, 265, 1-12.
78. Paiker, J.E.; Raal, F.J.; von Arb, M. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia. Ann. Clin. Biochem., 2000, 37 (Pt 2), 174-178.
79. Sherer, Y.; Tenenbaum, A.; Blank, M.; Shemesh, J.; Harats, D.; Fisman, E.Z.; Praprotnik, S.; Motro, M.; Shoenfeld, Y. Autoantibodies to oxidized lowdensity lipoprotein in coronary artery disease. Am. J. Hypertens, 2001, 14, 149-154.
80. van de Vijver, L.P.; Steyger, R.; van Poppel, G.; Boer, J.M.; Kruijssen, D.A.; Seidell, J.C.; Princen, H.M. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis, 1996, 122, 245-253.
81. Bergmark, C.; Wu, R.; Faire, D.U.; Lefvert, A.K.; Swedenborg, J. Patients with early onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arteriosclerosis, Thrombosis Vasc. Biol., 1995, 15, 441-445.
82. Troebs, M.; Renner, T.; Scherer, G.; Heller, W.D.; Geiss, H.C.; Wolfram, G.; Haas, G.M.; Schwandt, P. Nutrition, antioxidants, and risk factor profile of nonsmokers, passive smokers and smokers of the Prevention Education Program (PEP) in Nuremberg, Germany. Prev. Med., 2002, 34, 600-607.
83. Vaarala, O.; Manttari, M.; Manninen, V.; Tenkanen, L.; Puurunen, M.; Aho, K.; Palosuo, T. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation, 1995, 91, 23-27.
84. Clayson, D. B. Mechanistic and other considerations in cancer prevention. Cancer Lett., 1994, 83(1-2), 15-19.
85. Valavanidis, A.; Vlachogianni, T.; Fiotakis, K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health, 2009, 6(2), 445-462.
86. Pryor, W. A.; Dooley, M. M.; Church, D. F. Mechanisms of cigarette smoke toxicity: the inactivation of human alpha-1-proteinase inhibitor by nitric oxide/ isoprene mixtures in air. Chem. Biol. Interact., 1985, 54(2), 171-183.
87. Halliwell, B. Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic. Res., 1998, 29(6), 469-486.
88. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem., 2004, 266(1-2), 37-56.
89. Pilger, A.; Rüdiger, H. W. 8-Hydroxy-2'-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int. Arch. Occup. Environ. Health, 2006, 80(1), 1-15.
90. Cooke, M. S.; Olinski, R.; Evans, M. D. Does measurement of oxidative damage to DNA have clinical significance? Clin. Chim. Acta, 2006, 365(1- 2), 30-49.
91. Pourcelot, S.; Faure, H.; Firoozi, F.; Ducros, V.; Tripier, M.; Hee, J.; Cadet, J.; Favier, A. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine and 5- (hydroxymethyl) uracil in smokers. Free Radic. Res., 1999, 30(3), 173-180.
92. Kristenson, M.; Kucinskiené, Z.; Schäfer-Elinder, L.; Leanderson, P.; Tagesson, C. Lower serum levels of beta-carotene in Lithuanian men are accompanied by higher urinary excretion of the oxidative DNA adduct, 8- hydroxydeoxyguanosine. The LiVicordia study. Nutrition, 2003, 19(1), 11-15.
93. Loft, S.; Vistisen, K.; Ewertz, M.; Tjønneland, A.; Overvad, K.; Poulsen, H. E. Oxidative DNA damage estimated by 8-hydroxy-deoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis, 1992, 13(12), 2241-2247.
94. Asami, S.; Hirano, T.; Yamaguchi, R.; Tomioka, Y.; Itoh, H.; Kasai, H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res., 1996, 56(11), 2546-2549.
95. Asami, S.; Manabe, H.; Miyake, J.; Tsurudome, Y.; Hirano, T.; Yamaguchi, R.; Itoh, H.; Kasai, H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis, 1997, 18(9), 1763-1766.
96. Yao, Q. H.; Mei, S. R.; Weng, Q. F.; Zhang, P. D.; Yang, Q.; Wu, C. Y.; Xu, G. W. Determination of urinary oxidative DNA damage marker 8-hydroxy- 2'-deoxyguanosine and the association with cigarette smoking. Talanta, 2004, 63(3), 617-623.
97. Lodovici, M.; Casalini, C.; Cariaggi, R.; Michelucci, L.; Dolara, P. Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes. Free Radic. Biol. Med., 2000, 28(1), 13-17.
98. Besaratinia, A.; Van Schooten, F. J.; Schilderman, P. A.; De Kok, T. M.; Haenen, G. R.; Van Herwijnen, M. H.; Van Agen, E.; Pachen, D.; Kleinjans, J. C. A multi-biomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms. Carcinogenesis, 2001, 22(3), 395-401.
99. Zwingmann, I. H.; Welle, I. J.; van Herwijnen, M.; Engelen, J. J.; Schilderman, P. A.; Smid, T.; Kleinjans, J. C. Oxidative DNA damage and cytogenetic effects in flight engineers exposed to cosmic radiation. Environ. Mol. Mutagen, 1998, 32(2), 121-129.
100. van Zeeland, A. A., de Groot, A. J.; Hall, J.; Donato, F. 8- Hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat. Res., 1999, 439(2), 249-257.
101. Barbato, D. L.; Tomei, G.; Tomei, F.; Sancini, A. Traffic air pollution and oxidatively generated DNA damage: can urinary 8-oxo-7,8-dihydro-2- deoxiguanosine be considered a good biomarker? A meta-analysis. Biomarkers, 2010, 15(6), 538-45.
102. Besaratinia, A.; Van Schooten, F.J.; Schilderman, P.A.; De Kok, T.M.; Haenen, G.R.; Van Herwijnen, M.H.; Van Agen, E.; Pachen, D.; Kleinjans, J.C. A multi-biomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms. Carcinogenesis, 2001, 22(3), 395-401
103. Dandona, P.; Thusu, K.; Cook, S.; Snyder, B.; Makowski, J.; Armstrong, D.; Nicotera, T. Oxidative damage to DNA in diabetes mellitus. Lancet, 1996, 347(8999), 444-445.
104. Collins, A. R.; Raslová, K.; Somorovská, M.; Petrovská, H.; Ondrusová, A.; Vohnout, B.; Fábry, R.; Dusinská, M. DNA damage in diabetes: correlation with a clinical marker. Lancet, 1998, 25(3), 373-377.
105. Mecocci, P.; Polidori, M. C.; Ingegni, T.; Cherubini, A.; Chionne, F.; Cecchetti, R.; Senin, U. Oxidative damage to DNA in lymphocytes from AD patients. Neurology, 1998, 51(4), 1014-1017.
106. Tóth-Zsámboki, E.; Horváth, E.; Vargova, K.; Pankotai, E.; Murthy, K.; Zsengellér, Z.; Bárány, T.; Pék, T.; Fekete, K.; Kiss, R. G.; Préda, I.; Lacza, Z.; Gerö, D.; Szabó, C. Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes. Mol. Med., 2006, 12(9-10), 221-228.
107. Fracasso, M. E.; Doria, D.; Franceschetti, P.; Perbellini, L.; Romeo, L. DNA damage and repair capacity by comet assay in lymphocytes of white-collar active smokers and passive smokers (non- and ex-smokers) at workplace. Toxicol. Lett., 2006, 167(2), 131-141.
108. Hoffmann, H.; Speit, G. Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and the micronucleus test. Mutat. Res., 2005, 581(1-2), 105-114.
109. Giovannelli, L.; Saieva, C.; Masala, G.; Testa, G.; Salvini, S.; Pitozzi, V.; Riboli, E.; Dolara, P.; Palli, D. Nutritional and lifestyle determinants of DNA oxidative damage: a study in a Mediterranean population. Carcinogenesis, 2002, 23(9), 1483-1489.
110. Piperakis, S. M.; Petrakou, E.; Tsilimigaki, S. Effects of air pollution and smoking on DNA damage of human lymphocytes. Environ. Mol. Mutagen, 2000, 36(3), 243-249.
111. Thorne, D.; Wilson, J.; Kumaravel, T. S.; Massey, E. D.; McEwan, M. Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutat. Res., 2009, 673(1), 3-8.
112. Smith, C. C.; O'Donovan, M. R.; Martin, E. A. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis, 2006, 21(3), 185-190.
113. Osswald, K.; Mittas, A.; Glei, M.; Pool-Zobel, B. L. New revival of an old biomarker: characterisation of buccal cells and determination of genetic damage in the isolated fraction of viable leucocytes. Mutat. Res., 2003, 544(2-3), 321-329.
114. Pinhal, D.; Gontijo, A. M.; Reyes, V. A.; Salvadori, D. M. Viable human buccal mucosa cells do not yield typical nucleoids: impacts on the single-cell gel electrophoresis/Comet assay. Environ. Mol. Mutagen., 2006, 47(2), 117-126.
115. Danadevi, K.; Rozati, R.; Banu, B. S.; Grover, P. Genotoxic evaluation of welders occupationally exposed to chromium and nickel using the Comet and micronucleus assays. Mutagenesis, 2004, 19(1), 35-41.
116. Glei, M.; Habermann, N.; Osswald, K.; Seidel, C.; Persin, C.; Jahreis, G.; Pool-Zobel, B. L. Assessment of DNA damage and its modulation by dietary and genetic factors in smokers using the Comet assay: a biomarker model. Biomarkers, 2005, 10(2-3), 203-217.
117. Rojas, E.; Valverde, M.; Sordo, M.; Ostrosky-Wegman, P. DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat. Res., 1996, 370(2), 115-120.
118. Collins, A. R. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am. J. Clin. Nutr., 2005, 81(1), 261S-267S.
119. Wallace, S. S. Biological consequences of free radical-damaged DNA bases. Free Radic. Biol. Med., 2002, 33(1), 1-14.
120. Yamanaka, K.; Mizoi, M.; Tachikawa, M.; Hasegawa, A.; Hoshino, M.; Okada, S. Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. Toxicol. Lett., 2003, 143(2), 145-153.
121. Makropoulos, W.; Kocher, K.; Heintz, B.; Schwarz, E. R.; Mertens, P. R.; Stefanidis, I. Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Ren Fail., 2000, 22(4), 499-510.
122. Thier, R.; Brüning, T.; Kocher, K.; Blaszkewicz, M.; Makropoulos, V.; Sundberg, A.; Bolt, H. M. Determination of urinary thymidine glycol using affinity chromatography, HPLC and post-column reaction detection: a biomarker of oxidative DNA damage upon kidney transplantation. Arch. Toxicol., 1999, 73(8-9), 79-84.
123. Gracy, R. W.; Talent, J. M.; Kong, Y.; Conrad, C. C. Reactive oxygen species: the unavoidable environmental insult? Mutat. Res. 1999, 428(1-2), 17-22.
124. Beal, M. F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med., 2002, 32(9), 797-803.
125. Bernhard, D.; Csordas, A.; Henderson, B.; Rossmann, A.; Kind, M.; Wick, G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J., 2005, 19(9), 1096-1107.
126. Davies, K. J. Protein damage and degradation by oxygen radicals. I. general aspects. J. Biol. Chem., 1987, 262(20), 9895-9901.
127. Yeh, C. C.; Graham Barr, R.; Powell, C. A.; Mesia-Vela, S.; Wang, Y.; Hamade, N. K.; Austin, J. H.; Santella, R. M. No effect of cigarette smoking dose on oxidized plasma proteins. Environ. Res., 2008, 106(2), 219-225.
128. Kapaki, E.; Liappas, I.; Lyras, L.; Paraskevas, G. P.; Mamali, I.; Theotoka, I.; Bourboulis, N.; Liosis, I.; Petropoulou, O.; Soldatos, K. Oxidative damage to plasma proteins in patients with chronic alcohol dependence: the effect of smoking. In Vivo, 2007, 21(3), 523-528.
129. Young, I. S. Measurement of total antioxidant capacity. J. Clin. Pathol., 2001, 54(5), 339.
130. Lotito, S. B.; Frei, B. Relevance of apple polyphenols as antioxidants in human plasma: contrasting in vitro and in vivo effects. Free Radic. Biol. Med., 2004, 36(2), 201-211.
131. Koutelidakis, A. E.; Argiri, K.; Serafini, M.; Proestos, C.; Komaitis, M.; Pecorari, M.; Kapsokefalou, M. Green tea, white tea, and Pelargonium purpureum increase the antioxidant capacity of plasma and some organs in mice. Nutrition, 2009, 25(4), 453-458.
132. Stephens, J. W.; Khanolkar, M. P.; Bain, S. C. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis, 2009, 202(2), 321-329.
133. Serafini, M.; Villano, D.; Spera, G.; Pellegrini, N. Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr. Cancer, 2006, 56(2), 232-240.
134. Buico, A.; Cassino, C.; Ravera, M.; Betta, P. G.; Osella, D. Oxidative stress and total antioxidant capacity in human plasma. Redox. Rep., 2009, 14(3), 125-131.
135. Greabu, M.; Totan, A.; Battino, M.; Mohora, M.; Didilescu, A.; Totan, C.; Spinu, T. Cigarette smoke effect on total salivary antioxidant capacity, salivary glutathione peroxidase and gamma-glutamyltransferase activity. Biofactors, 2008, 33(2), 129-136.
136. Aycicek, A.; Erel, O.; Kocyigit, A. Decreased total antioxidant capacity and increased oxidative stress in passive smoker infants and their mothers. Pediatr. Int., 2005, 47(6), 635-639.
137. Somogyi, A.; Rosta, K.; Pusztai, P.; Tulassay, Z.; Nagy, G. Antioxidant measurements. Physiol. Meas., 2007, 28(4), R41-55.
138. Cao, G.; Prior, R. L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem., 1998, 44(6), 1309-1315.
139. Lykkesfeldt, J.; Viscovich, M.; Poulsen, H.E. Ascorbic acid recycling in human erythrocytes is induced by smoking in vivo. Free Radic. Biol. Med., 2003, 35(11), 1439-1447.
140. Calikoǧlu, M.; Unlü, A.; Tamer, L.; Ercan, B.; Buǧdayci, R.; Atik U. The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin. Chem. Lab. Med., 2002, 40(10), 1028-1031.
141. Bamonti, F.; Novembrino, C.; Ippolito, S.; Soresi, E.; Ciani, A.; Lonati, S.; Scurati-Manzoni, E.; Cighetti, G. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study. Clin. Chem. Lab. Med., 2006, 44(4), 391-395.
142. Kaehler, J.; Koeke, K.; Karstens, M.; Schneppenheim, R.; Meinertz, T.; Heitzer, T. Impaired capacity for acute endogenous fibrinolysis in smokers is restored by ascorbic acid. Free Radic. Biol. Med., 2008, 44(3), 315-321.
143. Stadler, N.; Eggermann, J.; Vöö, S.; Kranz, A.; Waltenberger, J. Smokinginduced monocyte dysfunction is reversed by vitamin C supplementation in vivo. Arterioscler Thromb. Vasc. Biol., 2007, 27(1), 120-126.
144. Sugiura, M.; Nakamura, M.; Ogawa, K.; Ikoma, Y.; Matsumoto, H.; Ando, F.; Shimokata, H.; Yano, M. Associations of serum carotenoid concentrations with the metabolic syndrome: interaction with smoking. Br. J. Nutr., 2008, 100(6), 1297-1306.
145. van Herpen-Broekmans, W.M.; Klöpping-Ketelaars, I.A.; Bots, M.L.; Kluft, C.; Princen, H.; Hendriks, H.F.; Tijburg, L.B.; van Poppel, G.; Kardinaal, A.F. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur. J. Epidemiol., 2004, 19(10), 915-921.
146. Rahman, I. Antioxidant therapies in COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 2006, 1(1), 15-29.
147. Rahman, I.; Adcock, I.M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J., 2006, 28(1), 219-242.
148. Bowler, R.P.; Barnes, P.J.; Crapo, J.D. The role of oxidative stress in chronic obstructive pulmonary disease. COPD, 2004, 1(2), 255-277.
149. Guénégou, A.; Leynaert, B.; Pin, I.; Le Moël, G.; Zureik, M.; Neukirch, F. Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population. Thorax, 2006, 61(4), 320-326.
150. Keranis, E.; Makris, D.; Rodopoulou, P.; Martinou, H.; Papamakarios, G.; Daniil, Z.; Zintzaras, E.; Gourgoulianis, K.I. Impact of dietary shift to higher antioxidant foods in COPD: A Randomized Trial. Eur. Respir. J., 2010 Feb 11. [Epub ahead of print]
151. Block, G.; Dietrich, M.; Norkus, E.; Jensen, C.; Benowitz, N.L.; Morrow, J.D.; Hudes, M.; Packer, L. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology, 2006, 17(4), 404-412.
152. Gregory, E. M.; Fridovich, I. Oxygen toxicity and the superoxide dismutase. J. Bacteriol., 1973, 114(3), 1193-1197.
153. Maier, C. M.; Chan, P. H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist, 2002, 8(4), 323-334.
154. Chance, B.; Sies, H.; Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev., 1979, 59(3), 527-605.
155. Gaber, A.; Tamoi, M.; Takeda, T.; Nakano, Y.; Shigeoka, S. NADPHdependent glutathione peroxidase-like proteins (Gpx-1, Gpx-2) reduce unsaturated fatty acid hydroperoxides in Synechocystis PCC 6803. FEBS Lett., 2001, 499(1-2), 32-36.
156. Hulea, S.A.; Olinescu, R.; Nita, S.; Crocnan, D.; Kummerow, F.A. Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J. Environ. Pathol. Toxicol. Oncol., 1995, 14, 173-180.
157. Ozguner, F.; Koyu, A.; Cesur, G. Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol. Ind. Health, 2005, 21(1-2), 21-26.
158. Aycicek, A.; Ipek, A. Maternal active or passive smoking causes oxidative stress in cord blood. Eur. J. Pediatr., 2008, 167(1), 81-85.
159. Abou-Seif, M.A. Blood antioxidant status and urine sulfate and thiocyanate levels in smokers. J. Biochem. Toxicol., 1996, 11, 133-138.
160. Orhan, H.; Evelo, C.T.; Sahin, G. Erythrocyte antioxidant defense response against cigarette smoking in humans--the glutathione S-transferase vulnerability. J. Biochem. Mol. Toxicol., 2005, 19(4), 226-233.
161. Hilbert, J.; Mohsenin, V. Adaptation of lung antioxidants to cigarette smoking in humans. Chest, 1996, 110, 916-920.
162. DiSilvestro, R.A.; Pacht, E.; Davis, W.B.; Jarjour, N.; Joung, H.; Trela- Fulop, K. BAL fluid contains detectable superoxide dismutase 1 activity. Chest, 1998, 113(2), 401-404.
163. Harju, T.; Kaarteenaho-Wiik, R.; Sirviö, R.; Pääkkö, P.; Crapo, J.D.; Oury, T.D.; Soini, Y.; Kinnula, V.L. Manganese superoxide dismutase is increased in the airways of smokers' lungs. Eur. Respir. J., 2004, 24(5), 765-771.
164. Ho, S.P.; Chan-Yeung, M.; Chow, K.K.; Ip, M.S.; Mak, J.C. Antioxidant enzyme activities in healthy Chinese adults: influence of age, gender and smoking. Respirology, 2005, 10(3), 305-309.
165. Yildiz, L.; Kayaoǧlu, N.; Aksoy, H. The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers. Clin. Chem. Lab. Med., 2002, 40(6), 612-615.
166. Greabu, M.; Totan, A.; Battino, M.; Mohora, M.; Didilescu, A.; Totan, C.; Spinu, T. Cigarette smoke effect on total salivary antioxidant capacity, salivary glutathione peroxidase and gamma-glutamyltransferase activity. Biofactors, 2008, 33(2), 129-136.